Deliberate ignorance: A systematic review of blinding in nursing clinical trials

Nursing Research

Volumn 60, Issue 1, 2011, Pages 9-16

  Polit, Denise F ^a   Gillespie, Brigid M ^b   Griffin, Ruth ^c  

^a Humanalysis Inc   (United States)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF MASSACHUSETTS DARTMOUTH   (United States)

Author keywords

bias; blinding; CONSORT guidelines; impact factor; randomized controlled trials; research design

Indexed keywords

ARTICLE; CHI SQUARE DISTRIBUTION; DOUBLE BLIND PROCEDURE; EPIDEMIOLOGY; FACTORIAL ANALYSIS; FINANCIAL MANAGEMENT; HUMAN; INFORMATION PROCESSING; JOURNAL IMPACT FACTOR; METHODOLOGY; NURSING RESEARCH; PRACTICE GUIDELINE; PUBLICATION; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS; STATISTICS;

BIAS (EPIDEMIOLOGY); CHI-SQUARE DISTRIBUTION; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; FACTOR ANALYSIS, STATISTICAL; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; JOURNAL IMPACT FACTOR; NURSING RESEARCH; PERIODICALS AS TOPIC; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUPPORT AS TOPIC; SAMPLE SIZE; SINGLE-BLIND METHOD;

EID: 78650853568     PISSN: 00296562     EISSN: None     Source Type: Journal    
DOI: 10.1097/NNR.0b013e3181ff7309     Document Type: Article

References (31)

1. Adetugbo, K., & Williams, H. (2000). How well are randomized controlled trials reported in the dermatology literature? Archives of Dermatology, 136(3), 381-385.
2. Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., et al. (2001). The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Annals of Internal Medicine, 134(8), 663-694. (Pubitemid 32322245)
3. Boutron, I., Estellat, C., & Ravaud, P. (2005). A review of blinding in randomized controlled trials found results inconsistent and questionable. Journal of Clinical Epidemiology, 58(12), 1220-1226.
4. Boutron, I., Moher, D., Altman, D. G., Schulz, K. F., & Ravaud, P. (2008). Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration. Annals of Internal Medicine, 148(4), 295-309. (Pubitemid 351665487)
5. Boutron, I., Tubach, F., Giraudeau, B., & Ravaud, P. (2004). Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials. Journal of Clinical Epidemiology, 57(6), 543-550.
6. Chan, A. W., & Altman, D. G. (2005). Epidemiology and reporting of randomised trials published in PubMed journals. Lancet, 365(9465), 1159-1162.
7. Devereaux, P. J., Manns, B. J., Ghali, W. A., Quan, H., & Guyatt, G. H. (2002). The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Controlled Clinical Trials, 23(4), 380-388.
8. Devereaux, P. J., Manns, B. J., Ghali, W. A., Quan, H., Lacchetti, C., Montori, V. M., et al. (2001). Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA, 285(15), 2000-2003.
9. Egger, M., Jü ni, P., Bartlett, C., Holenstein, F., & Sterne, J. (2003). How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Health Technology Assessment, 7(1), 1-76.
10. Fergusson, D., Glass, K. C., Waring, D., & Shapiro, S. (2004). Turning a blind eye: The success of blinding reported in a random sample of randomised, placebo controlled trials. BMJ, 328(7437), 432-437.
11. Haahr, M. T., & Hróbjartsson, A. (2006). Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors. Clinical Trials, 3(4), 360-365.
12. Higgins, J. P. T., & Green, S. (Eds). (2008). Cochrane handbook for systematic reviews of interventions (version 5.0.1). London, England: John Wiley & Sons.
13. Hróbjartsson, A., Forfang, E., Haahr, M. T., Als-Nielsen, B., & Brorson, S. (2007). Blinded trials taken to the test: An analysis of randomized clinical trials that report tests for the success of blinding. International Journal of Epidemiology, 36(3), 654-663.
14. Hsu, M. C., Chen, H. W., Hwu, Y. J., Chanc, C. M., & Liu, C. F. (2009). Effects of thermal therapy on uremic pruritus and biochemical parameters in patients having haemodialysis. Journal of Advanced Nursing, 65(11), 2397-2408.
15. Jüni, P., Altman, D. G., & Egger, M. (2001). Systematic reviews in healthcare: Assessing the quality of controlled clinical trials. BMJ, 323(7303), 42-46.
16. Kaptchuk, T. J. (1998). Intentional ignorance: A history of blind assessment and placebo controls in medicine. Bulletin of the History of Medicine, 72(3), 389-433.
17. Mills, E. J., Wu, P., Gagnier, J., & Devereaux, P. J. (2005). The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemporary Clinical Trials, 26(4), 480-487.
18. Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., et al. (2010). CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c869.
19. Montori, V. M., Bhandari, M., Devereaux, P. J., Manns, B. J., Ghali, W. A., & Guyatt, G. H. (2002). In the dark: The reporting of blinding status in randomized controlled trials. Journal of Clinical Epidemiology, 55(8), 787-790.
20. Parent, N., & Hanley, J. A. (2009). Assessing quality of reports on randomized clinical trials in nursing journals. Canadian Journal of Cardiovascular Nursing, 19(2), 25-39.
21. Polit, D. F., & Beck, C. T. (2008). Nursing research Generating and assessing evidence for nursing practice (8th ed). Philadelphia: Lippincott Williams & Wilkins.
22. Polit, D. F., & Gillespie, B. M. (2009). The use of the intention-to-treat principle in nursing clinical trials. Nursing Research, 58(6), 391-399.
23. Polit, D. F., & Gillespie, B. M. (2010). Intention-to-treat in randomized controlled trials: Recommendations for a total trial strategy. Research in Nursing & Health 33(4), 355-368.
24. Polit, D. F. (in press). Blinding during the analysis of research data.
25. Sackett, D. L. (2004). Turning a blind eye: Why we don't test for blindness at the end of our trials. BMJ, 328, 1136.
26. Schulz, K. F., Altman, D. G., & Moher, D., for the CONSORT Group. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. PLoS Medicine, 7(3), e1000251.
27. Schulz, K. F., Chalmers, I., & Altman, D. G. (2002). The landscape and lexicon of blinding in randomized trials. Annals of Internal Medicine, 136(3), 254-259.
28. Schulz, K. F., Chalmers, I., Hayes, R. J., & Altman, D. G. (1995). Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA, 273(5), 408-412.
29. Shadish, W.R., Cook, T., & Campbell, D. (2002). Experimental and quasi-experimental designs for generalized causal inference. Boston: Houghton Mifflin.
30. Smith, B. A., Lee, H. J., Lee, J. H., Choi, M., Jones, D. E., Bausell, R., et al. (2008). Quality of reporting randomized controlled trials (RCTs) in the nursing literature: Application of the Consolidated Standards of Reporting Trials (CONSORT). Nursing Outlook, 56(1), 31-37.
31. Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Juni, P., Altman, D. G., et al. (2008). Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: Meta-epidemiological study. BMJ, 336(7644), 601-605.